Third Rock Ventures
Latest statistics and disclosures from Third Rock Ventures's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Global Blood Therapeutics In, SAGE, BPMC, Eleven Biotherapeutics, Zafgen, and represent 100.00% of Third Rock Ventures's stock portfolio.
- Added to shares of these 1 stock: Global Blood Therapeutics In (+$622M).
- Started 1 new stock position in Global Blood Therapeutics In.
- Reduced shares in these 2 stocks: SAGE (-$99M), Zafgen (-$96M).
- Third Rock Ventures was a net buyer of stock by $428M.
- Third Rock Ventures has $1.1B in assets under management (AUM), dropping by 11.48%.
- Central Index Key (CIK): 0001600135
Portfolio Holdings for Third Rock Ventures
Third Rock Ventures holds 5 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Global Blood Therapeutics In | 58.1 | $622M | NEW | 15M | 42.16 |
|
| Sage Therapeutics (SAGE) | 25.5 | $273M | -26% | 6.4M | 42.32 |
|
| Blueprint Medicines (BPMC) | 14.7 | $158M | 7.4M | 21.34 |
|
|
| Eleven Biotherapeutics | 1.1 | $12M | 4.8M | 2.41 |
|
|
| Zafgen | 0.6 | $6.7M | -93% | 210k | 31.95 |
|
Past Filings by Third Rock Ventures
SEC 13F filings are viewable for Third Rock Ventures going back to 2013
- Third Rock Ventures 2015 Q3 filed Nov. 3, 2015
- Third Rock Ventures 2015 Q2 filed July 30, 2015
- Third Rock Ventures 2015 Q1 filed April 29, 2015
- Third Rock Ventures 2014 Q4 filed Jan. 26, 2015
- Third Rock Ventures 2014 Q3 filed Oct. 22, 2014
- Third Rock Ventures 2014 Q2 filed July 30, 2014
- Third Rock Ventures 2014 Q1 filed April 30, 2014
- Third Rock Ventures 2013 Q4 filed Feb. 14, 2014